Spectral Molecular Imaging Reaffirms Commitment To Early Detection Of Melanoma By Hyperspectral Imaging
Links shared publicly online about this topic.
- 706total visits
Spectral Molecular Imaging Reaffirms Commitment To Early Detection Of Melanoma By Hyperspectral Imaging
Cascade Technologies, Corp. (OTCBB: CSDT) announced today that, in response to significant recent attention to the Food and Drug Administration (FDA) panel evaluation of Mela Sciences' (Nasdaq: ME
View full resource at medicalnewstoday.com
Tags: Cancer, Skin Cancer, Melanoma, Drug, FDA, Science
Most Recently Shared on November 23, 2010 at 3:05 pm By:
Spectral Molecular Imaging Reaffirms Commitment To Early Detection Of Melanoma By Hyperspectral Imaging http://mnt.to/3MZV #medicaldevices
Also Shared By:
Advertisement
Drugs and Devices OW
@Drugs_Devices
Spectral Molecular Imaging Reaffirms Commitment To Early Detection Of Melanoma By Hyperspectral Imagi... http://mnt.to/f/3MZV #MedDevice
1 year ago...